Barclays Keeps Their Hold Rating on DaVita (DVA)
TipRanksApr 15 04:26 ET
Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and DaVita (DVA)
TipRanksApr 3 04:01 ET
Deutsche Bank Adjusts DaVita Price Target to $135 From $120, Maintains Hold Rating
MT NewswiresMar 8 10:48 ET
DaVita Analyst Ratings
BenzingaMar 6 16:05 ET
TD Cowen Sticks to Their Hold Rating for DaVita (DVA)
TipRanksFeb 25 20:55 ET
DaVita Analyst Ratings
BenzingaFeb 20 09:16 ET
DaVita Analyst Ratings
BenzingaFeb 15 11:53 ET
UBS Adjusts DaVita Price Target to $145 From $134, Maintains Buy Rating
MT NewswiresFeb 15 11:29 ET
DaVita Analyst Ratings
BenzingaFeb 14 14:50 ET
UBS Adjusts DaVita Price Target to $134 From $113, Maintains Buy Rating
MT NewswiresFeb 14 12:29 ET
DaVita Analyst Ratings
BenzingaFeb 14 08:13 ET
Maintaining a Sell Rating on DaVita Amid Long-Term Growth Concerns and Cost Management Challenges
TipRanksFeb 14 05:45 ET
UBS Maintains Buy on DaVita, Lowers Price Target to $113
BenzingaNov 17, 2023 10:58 ET
DaVita Analyst Ratings
BenzingaNov 17, 2023 10:56 ET
Deutsche Bank Adjusts DaVita Price Target to $90 From $113, Maintains Hold Rating
MT NewswiresNov 8, 2023 10:43 ET
DaVita's Strong Quarter Overshadowed by Volume Normalization and Pricing Concerns: A Sell Rating Reiteration
TipRanksNov 8, 2023 05:57 ET
Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), DaVita (DVA) and Demant (OtherWILLF)
TipRanksNov 8, 2023 03:40 ET
Hold Rating on DaVita's Stock: An Analysis of 3Q23 Results, Raised 2023 Guidance, and Anticipated Share Repurchase Program
TipRanksNov 7, 2023 21:45 ET
Truist Securities Maintains Hold on DaVita, Lowers Price Target to $104
BenzingaOct 11, 2023 15:58 ET
DaVita Analyst Ratings
BenzingaOct 11, 2023 15:57 ET
No Data
No Data